Enzymatically Modified Low‐Density Lipoprotein Is Present in All Stages of Aortic Valve Sclerosis: Implications for Pathogenesis of the Disease
Main Authors: | Twardowski, Laura, Cheng, Fei, Michaelsen, Jens, Winter, Stefan, Hofmann, Ute, Schaeffeler, Elke, Müller, Simon, Sonnenberg, Maike, Steuer, Kristin, Ott, German, Schwab, Matthias, Franke, Ulrich F. W., Torzewski, Michael |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845139/ |
Similar Items
-
On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety
Published: (1995) -
Pharmacogenomics: a key component of personalized therapy
by: Schwab, Matthias, et al.
Published: (2012) -
Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)
by: Nies, Anne T., et al.
Published: (2011) -
Modified Lipoprotein-Derived Lipid Particles Accumulate in Human Stenotic Aortic Valves
by: Lehti, Satu, et al.
Published: (2013) -
DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
by: Schaeffeler, Elke, et al.
Published: (2011)